Evidence map›Paper›PMID 28584851›Full record

ArticleOpen forum infectious diseases2017

Successful Pre- and Posttransplant Sofosbuvir-Based Anti-Hepatitis C Virus Treatment in Persons Living With Human Immunodeficiency Virus Infection.

Giovanni Guaraldi, Roberto Rossotti, Gabriella Verucchi, Marcello Tavio, Luisa Pasulo, Barbara Beghetto, Giovanni Dolci, Giulia Nardini, Lorenzo Badia, Anna Magliano and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open forum infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Giovanni GuaraldiInfectious Diseases Departments of University of Modena, Italy.
Roberto RossottiASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
Gabriella VerucchiUniversity of Bologna, Italy.
Marcello TavioAzienda Ospedaliera Universitaria Ospedali Riuniti, Ancona, Italy; and.
Luisa PasuloGastroenterology Department ASST Papa Giovanni XXIII, Bergamo, Italy.
Barbara BeghettoInfectious Diseases Departments of University of Modena, Italy.
Giovanni DolciInfectious Diseases Departments of University of Modena, Italy.
Giulia NardiniInfectious Diseases Departments of University of Modena, Italy.
Lorenzo BadiaUniversity of Bologna, Italy.
Anna MaglianoAzienda Ospedaliera Universitaria Ospedali Riuniti, Ancona, Italy; and.
Maria Cristina MoioliASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
Massimo PuotiASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
HIV/HCV Italian Liver Transplant Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This retrospective study reports the data of sofosbuvir-based anti-hepatitis C virus treatment in 24 candidates and 24 recipients of liver transplantation coinfected with human immunodeficiency virus. Sustained virologic response was cumulatively 85% (90% and 100% in those treated with optimal schedules pre- and posttransplant, respectively).

Indexed as

HCVHIVliver transplantationNS5A inhibitorssofosbuvir.

Identifiers

PMID28584851
PMCPMC5451199

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.